Literature DB >> 2330191

Outpatient and abbreviated hospitalization for vitreoretinal surgery.

D Wilson1, C C Barr.   

Abstract

We retrospectively reviewed 255 consecutive scleral buckling and vitrectomy operations dividing the patients into two groups. One group was managed traditionally with general anesthesia and postoperative hospitalization. The second group was managed with local anesthesia and with no hospitalization or abbreviated hospitalization whenever possible. There was no difference in the technical or functional success rates achieved in the two groups. We conclude that vitreoretinal surgery may be performed safely and effectively on an outpatient basis in selected cases.

Entities:  

Mesh:

Year:  1990        PMID: 2330191

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  5 in total

1.  Prospects for day-case vitreoretinal surgery.

Authors:  P Leaver
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

2.  Evaluation of outpatient experience with vitreoretinal surgery.

Authors:  C S Cannon; J G Gross; I Abramson; W J Mazzei; W R Freeman
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

Review 3.  Local versus general anaesthesia for adults undergoing pars plana vitrectomy surgery.

Authors:  Ana Licina; Sharan Sidhu; Jing Xie; Crispin Wan
Journal:  Cochrane Database Syst Rev       Date:  2016-09-19

4.  Retrospective evaluation of two-year results with a filtering trabeculotomy in comparison to conventional trabeculectomy by exact matching.

Authors:  Alicja Strzalkowska; Peter Strzalkowski; Yousef Al Yousef; Jost Hillenkamp; Franz Grehn; Nils A Loewen
Journal:  F1000Res       Date:  2020-10-15

5.  HIOP-Reader: Automated Data Extraction for the Analysis of Manually Recorded Nycthemeral IOPs and Glaucoma Progression.

Authors:  Vaia Agorastou; Julian Schön; Raoul Verma-Fuehring; Mohamad Dakroub; Jost Hillenkamp; Frank Puppe; Nils A Loewen
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.